BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD. - Board Meeting Outcome for Submission Of Unaudited Quarterly Financial Results For The Quarter Ended December 2021 As Compliance Of LODR 2015
09 Feb 2022
In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter ended December 2021 approved by the Board of the Company in its Meeting on 08.02.2022.
The XBRL filing will be made succeeding to this.
Source:
BSE India